Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-08

Clinical Trial Update: Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating microbiota transplant therapy for alopecia areata and related conditions is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Microbiota transplant therapy

Snippet

Sponsor: University of Minnesota | Conditions: Alopecia Areata, Alopecia Totalis | Phase 2 | Status: RECRUITING